Chikungunya virus is widespread throughout the tropics, where it causes recurrent
outbreaks of chikungunya fever. In recent years, outbreaks have afflicted populations in East …

The largest epidemic ever recorded for chikungunya, a disease caused by infection with the
chikungunya virus (CHIKV), began in Africa in 2004 and spread to> 100 countries on four …

Background VLA1553 is a live-attenuated vaccine candidate for active immunisation and
prevention of disease caused by chikungunya virus. We report safety and immunogenicity …

Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the
causative agent of the coronavirus disease 2019 (COVID-19) pandemic, are urgently …

Alphaviruses are arthropod-transmitted RNA viruses that cause epidemics of human
infection and disease on a global scale. These viruses are classified as either arthritogenic …

Beginning in 2004, chikungunya virus (CHIKV) went from an endemic pathogen limited to
Africa and Asia that caused periodic outbreaks to a global pathogen. Given that outbreaks …

The present use of mRNA vaccines against COVID-19 has shown for the first time the
potential of mRNA vaccines for infectious diseases. Here we will summarize the current …

Chikungunya virus (CHIKV) is a reemerging mosquito-borne virus that causes swift
outbreaks. Major concerns are the persistent and disabling polyarthralgia in infected …

Background Chikungunya disease, which results in incapacitating arthralgia, has been
reported worldwide. We developed a live-attenuated chikungunya virus (CHIKV) vaccine …

Chikungunya virus (CHIKV) is a re-emergent arthropod-borne virus (arbovirus) that causes a
disease characterized primarily by fever, rash and severe persistent polyarthralgia. In the …